Introduction
============

The percentage of the population over the age of 65 is steadily increasing and is expected to continue in the foreseeable future (United-Nations, [@B92]), with people over the age of 80 now among the fastest growing subset of the population (Jarad, [@B37]). Currently, cardiovascular diseases (CVDs) are the most common cause of death among elderly patients in the Western world, accounting for more than 40% of all mortalities among people aged 65--74, and 60% of people 85 years and older (Ungvari et al., [@B91]). Moreover, almost 70% of the population over the age of 70 has some degree of hypertension, which reflects the fact that blood pressure increases with age (Pedelty and Gorelick, [@B67]; Wills et al., [@B95]).

Despite the increased risk of CVD associated with aging, evidence indicates that health among the elderly population is improving, as illustrated by falling rates of ischemic heart disease, heart failure, and cerebrovascular disease among people over the age of 80 (National Heart, Lung and Blood Institute, [@B61]; Perls, [@B68]). The inevitable consequence of increasing life expectancy is that the aging population constitutes a greater proportion of patients undergoing medical treatments and presenting for surgery.

Since the elderly are associated with a higher incidence of disease and concurrent use of medications, intraoperative management of these patients can be challenging. For example, diabetes and hypertension are highly prevalent in this population and are known to impact various aspects of circulatory function. Medications such as beta blockers and angiotensin converting enzyme (ACE) inhibitors are commonly used in this age group, and the resultant drug interactions may also compromise hemodynamic stability and lead to untoward events. Even in the absence of these complicating factors, elderly patients are intrinsically more susceptible to the circulatory effects of anesthetic agents and other cardiovascular stressors due to the progressive structural and functional changes in the circulation that invariably occur with aging.

Due to increasing life expectancies in an ever-growing elderly population, studies pertaining to the circulatory changes in these patients are becoming increasingly timely and relevant. The focus of the present review is to consolidate the available information on aging as it pertains to vascular function and the intraoperative maintenance of hemodynamic stability in the elderly patient. Thus, rather than focusing on the mechanisms of aging that leads to progressive deterioration of circulatory function over a long period of time, we discuss aspects of the aging vasculature that are more relevant in the acute regulation of blood pressure -- an important aspect in the intraoperative setting. We subsequently discuss the vascular effects of certain notable anesthetic agents, and where evidence is available, discuss some of the mechanisms underlying their effects. For more detailed reviews on the progressive vascular changes that occur with aging, see the following references: Seals et al. ([@B75], Mitchell ([@B58]), Lekontseva et al. ([@B47]), as well as those included in this issue of *Frontiers in Physiology*.

Hemodynamic Instability and Aging
=================================

One of the greatest challenges in intraoperative care for elderly patients is the maintenance of stable hemodynamic parameters. In particular, prevention of hypotension resulting in reduced end-organ perfusion is a primary concern. Elderly patients are more prone to developing hypotension in general (Johnson et al., [@B38]; Caird et al., [@B13]; Lipsitz et al., [@B49]; Shannon et al., [@B77]), but this may be exacerbated in surgery due to the fact that many anesthetic agents are, by nature, hypotensive-inducing. Hypoperfusion may be particularly harmful in elderly patients for several reasons. First, organs in elderly patients are accustomed to perfusion at higher pressures (Hoffman et al., [@B32]; Harrison et al., [@B29]; Tomanek, [@B87]); thus, in a patient with ischemic heart disease and long-standing hypertension, a decrease in blood pressure intraoperatively toward the "low-normal range" of healthy adults may actually be detrimental. Second, due to an age-associated decline in function, organs in the elderly appear more susceptible to loss of perfusion (Corcoran and Hillyard, [@B16]).

Given the prevalence of hypertension in the elderly population, it is perhaps counterintuitive that these patients are more susceptible to intraoperative hypotension (Reich et al., [@B71]). This hemodynamic "instability" stems from multiple factors acting in concert. First, the circulation in elderly patients is highly dependent on preload, such that alterations in vascular tone can have a large influence on cardiac output and end-organ perfusion (Corcoran and Hillyard, [@B16]). Second, evidence indicates that "physiologic reserve" declines with age (Lipsitz, [@B48]). Physiologic reserve broadly refers to a system's capacity to cope with homeostatic perturbations. In the context of acute blood pressure regulation, changes from the operating setpoint are buffered by two principal mechanisms: (1) baroreceptor reflex, which modulates autonomic nervous system activity; and (2) vascular responsiveness to shear stress, which is coupled to endothelial nitric oxide (NO) production (Park, [@B64]). Both baroreceptor capacity to buffer acute blood pressure changes and shear stress-induced production of NO are markedly attenuated in elderly patients (Mancia et al., [@B55]), resulting in a diminished capacity to cope with alterations in the blood pressure.

A third factor that contributes to the hemodynamic instability in the elderly is the downregulation of vasodilatory mechanisms (e.g., NO, prostaglandins) and concomitant upregulation of vascular constrictor mechanisms \[endothelin (ET)-1, sympathetic nervous system (SNS) stimulation, renin--angiotensin system (RAS) activity\]. The sudden removal of these vasoconstrictor signaling mechanisms by anesthetic agents (see below) may contribute to profound and prolonged hypotension. A case in point is the increased tonic SNS activity that occurs with aging (Seals and Esler, [@B74]). The consequences of this increased SNS activity are several-fold, but perhaps the most important implications are that (1) there is a greater autonomic support of arterial pressure in elderly patients compared to young patients (Jones et al., [@B39]), and (2) there is reduced responsiveness of alpha and beta receptors to further increases in catecholamine release (Mack, [@B52]), which may implicate receptor downregulation and post-receptor desensitization mechanisms (Xiao and Lakatta, [@B96]; Pilotti et al., [@B69]). Iatrogenic removal of this sympathetic "overstimulation" may therefore result in an exaggerated reduction in vascular tone, due to the increased reliance of peripheral vascular resistance on autonomic stimulation, thereby resulting in hypotension. Moreover, there is a compounding effect of reduced baroreceptor sensitivity which results in reduced sympathetic discharge (McConnell et al., [@B57]), coupled with reduced peripheral tissue responsiveness to released catecholamines (Ramos Macias et al., [@B70]; Sugiyama et al., [@B81]; Davy et al., [@B19]; Dinenno et al., [@B20]). In all, the elderly circulatory system has a significantly reduced capacity to cope with hemodynamic disturbances, particularly in the case when SNS activity is reduced.

Vascular Changes Associated with Aging and Effects of Anesthesia: Specific Agents
=================================================================================

Anesthetics can influence hemodynamic stability directly by altering cardiac function, vascular reactivity, or affecting cardiovascular reflexes (Mallow et al., [@B54]; Westenskow et al., [@B94]; Bennett and Stanley, [@B7]; Waxman et al., [@B93]; Brismar et al., [@B11]; Fairfield et al., [@B24]). Because cardiac and vascular function are in many ways compromised with aging, the circulatory effects of anesthetics are exacerbated in the elderly (Tokics et al., [@B86]). Given the emphasis of the present review, we focus on the vascular effects of two primary classes of general anesthetics: inhalational and intravenous. It is also noteworthy that due to changes in pharmacokinetics, elderly patients tend to be more sensitive to the neurological effects of anesthetic agents. Although not discussed herein, it is possible that the circulatory effects of anesthetic agents may also be exacerbated in the elderly due to greater distribution to the brain, particularly if greater concentrations are achieved in the vasoregulatory centers; for information on these aspects of anesthetic agents in the aging population, see the following reviews (Kalker et al., [@B40]; Shafer, [@B76]; Kruijt Spanjer et al., [@B44]).

Inhalational anesthetics
------------------------

While many of the vascular effects of anesthetic agents have been well-characterized in young patients and animals, relatively few studies have been done in the elderly or in animal models of aging. Inhalational anesthetic agents such as sevoflurane, isoflurane, and desflurane are widely acknowledged to cause greater hypotension in elderly patients than in young patients, albeit the scientific studies supporting this observation are generally lacking (Ebert, [@B22]). The principal cause of hypotension appears to implicate a loss vascular tone and reduction in total peripheral resistance (Lynch, [@B51]; Housmans and Murat, [@B33]; Pagel et al., [@B62], [@B63]; Kikura and Ikeda, [@B43]), although the specific mechanisms are not clear. There is evidence that inhalational anesthetic agents decrease SNS activity, resulting in reduced vascular tone and diminished baroreceptor responsiveness in the wake of blood pressure fluctuations (Seagard et al., [@B73]; Tanaka et al., [@B84]). This is important because sudden decreases in SNS activity may cause excessive and prolonged vasodilation in the elderly, as described above. Yu et al. ([@B102]) have also shown that inhalational anesthetics may decrease vascular tone through inhibition of the RAS, which is known to be upregulated in aging (Baruch, [@B5]; Diz, [@B21]). Given that angiotensin II is a strong vasoconstrictor and may lead to increased vascular tone, it is tempting to speculate that the sudden withdrawal of this system may produce a profound hypotension, analogous to the situation involving the SNS, as described above. However, evidence that directly implicates the RAS in this exaggerated hypotensive effect is presently lacking.

Inhalational anesthetics have also been shown to have direct vasodilatory effects on the vasculature, which may be implicated in the exaggerated effects in the elderly. In isolated vessels of several species, inhalational anesthetics mitigate the contractile responses to potassium chloride or norepinephrine; this effect was observed whether the endothelium was intact or not (Akata, [@B1]), suggesting a direct effect on vascular smooth muscle. Indeed, studies have shown that many such anesthetic agents influence calcium mobilization and sensitization (Tsuneyoshi et al., [@B89]; Akata, [@B1]) as well as potassium channel function (Tanaka et al., [@B83]) in vascular smooth muscle cells, with corresponding changes in vessel contractility. Given the importance of calcium channels and potassium channels in vascular tone, direct actions on these targets could potentially influence vascular responses to anesthetics in aging patients, although little information is available on the age-related changes with ion channels in the vasculature. There is evidence for diminished expression of large-conductance calcium-activated potassium channels in aging in both rodents and humans (Marijic et al., [@B56]; Toro et al., [@B88]), although their contribution to the vascular effects of inhalational anesthetic agents in aging is not currently known.

Inhalational anesthetics also have vasodilatory-promoting effects on endothelial function. Isoflurane has been shown to decrease ET-1 production (Boillot et al., [@B10]), which may have a profound effect in the elderly population given the increased ET-1 contribution to vascular tone with age (Stauffer et al., [@B79]; Goel et al., [@B25]). Inhalational anesthetics could also cause excessive vasodilation in the elderly via an antioxidant effect. While these agents do not appear to have intrinsic antioxidant effects *per se*, certain agents such as isoflurane and sevoflurane have been shown to increase endogenous antioxidant enzyme activity (Yang et al., [@B99]; Crystal et al., [@B18]), which may have a role in decreasing vascular tone. Indeed, in aging patients, a progressive increase in reactive oxygen species production is a well-defined etiological mechanism of vascular dysfunction and increased vasoconstriction (Herrera et al., [@B31]; Ungvari et al., [@B91]).

Interestingly, in contrast to those aforementioned studies, inhalational anesthetics have also been shown to increase vascular responsiveness to norepinephrine and KCl in rat mesenteric arteries, an effect that is entirely dependent on an intact endothelium (Stone and Johns, [@B80]; Izumi et al., [@B35], [@B36]; Yoshino et al., [@B101]). Similarly, several groups have shown that these agents also inhibit endothelial-dependent vasodilation (Muldoon et al., [@B60]; Toda et al., [@B85]; Uggeri et al., [@B90]; Yoshida and Okabe, [@B100]; Park et al., [@B65]). The mechanisms underlying this latter observation are not clear, although neither NO, endothelium-derived hyperpolarizing factor, prostaglandin H synthase, and lipoxygenase pathways, nor ET-1, angiotensin II, or serotonin receptors appear to be implicated; calcium, potassium, and sodium channels are obvious potential targets. Taken together, these studies demonstrate that anesthetic effects on the endothelium, are in part, vasoconstrictor in nature. Although puzzling, this apparent disparity may be reconciled by the fact that the net effect of an agent is the sum of all simultaneous effects on the vessel (Muldoon et al., [@B60]). Therefore, while the endothelial effects of anesthetics appears to be vasoconstrictor in nature, the net effect, taking into account the effects of inhaled anesthetics on smooth muscle function, SNS, RAS, and other local and humoral factors, is vasodilatory. Since elderly patients are known to have altered endothelial secretory profiles, it is tempting to speculate that the hypotensive effects of inhalational anesthetics stem, at least in part, from mitigated endothelial vasoconstrictor effects producing an overall enhanced vasodilation. Studies are needed to directly test this hypothesis.

Intravenous anesthetics
-----------------------

### Etomidate

In vessels from young rats, etomidate causes direct vasodilation *ex vivo* (Bazin et al., [@B6]), involving increased vasodilator prostaglandins (Asher et al., [@B4]) and decreased ET-1 production (Hayashi et al., [@B30]). However, *in vivo*, administration of etomidate has little effect on blood pressure in young patients; in fact, its hemodynamic stability during induction of general anesthesia make it a preferred agent in many clinical scenarios (Gooding and Corssen, [@B26]; Criado et al., [@B17]). The hemodynamic stability of etomidate appears to stem from a lack of inhibition of SNS function (Ebert et al., [@B23]; Robinson et al., [@B72]). Thus, despite causing direct vasodilation, hemodynamic perturbations are transient and easily corrected by baroreceptor stimulation of heart rate and contractility. However, when administered to elderly patients, etomidate causes a 20--30% decrease in blood pressure (Larsen et al., [@B46]). This hypotensive effect is not well understood, although recent studies have provided insights into its mechanism. The reason may be due in part to the interaction between etomidate and adrenoceptor signaling. Etomidate enhances norepinephrine-induced constriction in mesenteric resistance arteries in young rats, resulting in increased vascular tone; this effect appears to be lost in aged rats (Shirozu et al., [@B78]). The authors of this study suggested that hypotension with etomidate in aged patients is not due to direct actions on the vasculature but rather due to interference with norepinephrine-induced vasoconstriction. Interestingly, Ebert et al. ([@B23]) demonstrated that etomidate does not reduce overall release of catecholamines from sympathetic nerve terminals, suggesting that the majority of the blood pressure-lowering effects in the elderly may stem from altering the adrenoceptor responsiveness to catecholamines. Thus, despite increased NE levels in aging patients, etomidate-induced decrease in adrenoceptor responsiveness results in a more profound vasodilatory effect.

Etomidate is also known to cause adrenocortical suppression (Allolio et al., [@B2]; Lamberts et al., [@B45]), resulting in diminished cortisol release which can be problematic in certain patients (e.g., septic patients). Cortisol increases blood pressure principally by increasing sensitivity of the vasculature to catecholamines. Thus, etomidate-induced reduction in cortisol production may also play a role in causing hypotension in the intraoperative period, again making elderly patients more susceptible to this effect due to the progressive loss of catecholamine responsiveness with aging. This is supported by a recent case report of an elderly patient given a single dose of etomidate causing refractory hypotension that was only reversible with cortisol administration (Lundy et al., [@B50]). It is noteworthy that this mechanism is likely in addition to that described by Shirozu et al. ([@B78]) since those experiments were done in isolated vessels.

### Propofol

It was recently reported that the use of propofol over other general anesthetics, as well as age of the patient, are independent predictors of clinically significant hypotension in patients undergoing general anesthesia (Reich et al., [@B71]). The majority of hypotensive effects of propofol appear to occur via reduced systemic vascular resistance. Part of this effect may stem from the fact that propofol, in contrast to etomidate, diminishes SNS function (Robinson et al., [@B72]), which may result in vasodilation. Moreover, loss of SNS activity results in decreased compensatory heart rate and contractility in the wake of hypotension, may be an important contributor to its hypotensive effects in the elderly, as described above. Propofol has also been shown to cause direct relaxation in several vascular beds, \[e.g., aorta in rat (Boillot et al., [@B9]), coronary artery in the pig (Park et al., [@B66]), and mesenteric arteries in humans and rats (Moreno et al., [@B59]; Yamazaki et al., [@B98])\], although studies by Yamashita et al. ([@B97]) and Kamitani et al. ([@B41]) have shown opposite effects in rabbits, which may suggest species differences. In young animals, propofol increases NO production in isolated endothelial cells concomitant with decreased ET-1 release from the endothelium (Cheng et al., [@B14]). Tanabe et al. ([@B82]) also showed that propofol inhibits ET-1 signaling in vascular smooth muscle. Given the role of diminished NO and increased ET-1 as important mechanisms in vascular aging, it seems plausible that these mediators may be implicated in the exaggerated hypotensive effects in elderly patients.

In our studies, we demonstrated that propofol causes enhanced mesenteric artery relaxation in aged rats when compared to young, and this effect was attributed to increased NO bioavailability (Gragasin and Davidge, [@B28]). We also demonstrated that the combination of antioxidant enzymes superoxide dismutase and catalase enhance vasodilation to acetylcholine similar to propofol in aged rats (Gragasin and Davidge, [@B28]). On the basis of these studies, we suggested that propofol may exert part of its vasodilatory effects via intrinsic antioxidant effects (Ansley et al., [@B3]), since it is structurally similar to α-tocopherol (vitamin E). Thus, we speculate that the vasodilatory effect may be more pronounced because aging vessels have increased oxidative stress. These data may also suggest that the use of NO donors to treat acute hypertensive crises intraoperatively may be harmful in elderly patients anesthetized with propofol. Indeed, it is already known that elderly patients have an increased sensitivity to nitroglycerin causing hypotension (Cahalan et al., [@B12]), and the presence of propofol may cause an unwanted synergistic blood pressure-lowering effect.

More recently, we investigated the effects of propofol in aged animals treated with the ACE inhibitor captopril. ACE inhibitors are commonly prescribed medications for blood pressure control in elderly patients, and it is well documented that these treated patients exhibit greater hypotension under general anesthesia (Bertrand et al., [@B8]; Comfere et al., [@B15]; Kheterpal et al., [@B42]). It has been suggested that there may be an interaction between ACE inhibitors and propofol which causes severe hypotension (Malinowska-Zaprzalka et al., [@B53]). In an aging rodent model, chronic treatment with captopril increases endothelial-dependent vasodilation in the presence of propofol (unpublished data). Interestingly, NO was not responsible for the differential response observed between control and captopril-treated rats (unpublished data); thus there may be alterations in other vasodilating mechanisms such as endothelial-derived hyperpolarizing factor (Hutri-Kahonen et al., [@B34]; Goto et al., [@B27]). The caveat is that isolated vessels may not recapitulate *in vivo* vascular responses, and therefore further investigation using integrated, whole-animal approaches are needed to identify the mechanisms underlying this enhanced relaxation.

Conclusion
==========

Aging is associated with a multitude of changes at the vascular level, including structural changes, enhanced oxidative stress, and altered secretory profiles of vasoconstrictor and vasodilators. Anesthetic agents may acutely alter this balance leading to excessive and unwanted vasodilation in the elderly, and elucidating the underlying mechanisms dictating vascular function and its changes with age are therefore crucial. Moreover, given that elderly patients often have existing co-morbidities, additional studies are needed to elucidate the mechanisms of anesthetic-induced changes in hemodynamics in the presence of overt disease, such as hypertension, diabetes, chronic kidney disease, or more surreptitious conditions associated with aging, such as nutritional deficiencies (e.g., iron deficiency), which may have additional effects on vascular function. From a clinical perspective, the Anesthesiologist is tasked with making important decisions about drug use in elderly patients, considering factors such as patient safety, neurological recovery, and drug availability. Gaining further knowledge of the mechanisms of action of anesthetic agents at the vascular level as well in intact animal models can potentially be translated to the bedside, possibly changing clinical practice by enhancing management of circulatory health in the elderly during the intraoperative period.
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